ylliX - Online Advertising Network
General Market News

Evogene: Bullish With Canonic’s Entry Into Israeli Medical Cannabis Markets

Evogene: Bullish With Canonic's Entry Into Israeli Medical Cannabis Markets

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

Canonic, a subsidiary of Evogene, will bring its unique cannabis products to the Israeli cannabis market in 2022. The company has been hard at work deciphering the cannabis genome and breeding special strains to treat specific conditions, like chronic pain and inflammation.

...read full article on Seeking Alpha

ylliX - Online Advertising Network